ScinoPharm was established in 1997 by a group of veteran pharmaceutical executives who had years of experience working for leading U.S. and international pharmaceutical companies. They helped lay the strong technical and quality foundation for ScinoPharm and also oversaw the establishment of a highly competent management team that is in charge today.
Chih-Hsien Lo | Chairman and General Chief Strategy Officer
Chairman of Uni-President Enterprises Corp.
Yung-Fa Chen | CEO Ph.D. Chemistry
Dr. Chen has over 25 years of experience in the management of chemical & pharmaceutical businesses with in-depth experiences in strategic planning, chemical and pharmaceutical R&D, supply chain management, quality control and assurance, cGMP compliance and formulation development. Dr. Chen joined ScinoPharm since 1998 and has held various management positions of increasing responsibilities. He became Sr. R&D Director in 2002 and was later promoted to Vice President of Advanced Technology Development in 2003. He was appointed as Chief Operating Officer of ScinoPharm Kun-Shan Biochemical in 2006, and since then has demonstrated outstanding results in building up our operation base in China with a skilled local team, which provides a firm foothold for our expansion in China and eventually becoming the backbone team of the current ScinoPharm’s Changshu site. In 2009, he was promoted to Corporate Vice President of R&D, overseeing the overall operations and management of the R&D teams in both Tainan and China. In 2012, he was further promoted to Senior Vice President of R&D and Chief Technology Officer. Prior to joining ScinoPharm in 1998, Dr. Chen was employed for 7 years in the Refining and Manufacturing Research Center of Chinese Petroleum Corporation (CPC) where he worked on specialty chemical products and in process R&D. Before CPC, he was an adjunct professor of Chemistry at Tunghai University in Taiwan for 5 years, and at Wayne State University as a postdoctoral fellow of Medicinal Chemistry for two years. Dr. Chen holds a Ph.D. in Chemistry from Wayne State University, a M.S. in Chemistry from National Taiwan University, and a B.S. from Tunghai University. Dr. Chen is the holder of eighteen patents.
Portia Lin | Vice-President of Marketing and Sales and Chief Strategy Officer| General Manager of ScinoPharm Shanghai Biochemical Technology, Ltd. Ph.D. Chemistry
Dr. Portia Lin began working at ScinoPharm in 1999, starting as a Research Scientist in R&D. After 2 years, in 2001, Dr. Lin was selected to join the Marketing & Sales group at ScinoPharm. She organized and initiated the group responsible for the development of sales for generic APIs. She is now in charge of the Marketing & Sales team for global sales activities for generic products and for ScinoPharm’s Contract Research and Manufacturing business. Dr. Lin holds a Ph.D. in chemistry from Hong Kong Polytech University, and a B.S and M.S. in chemistry from Chung-Hsing University in Taiwan.
Chih-Fang (Freon) Chen | Vice-President of Operations
Chih-Fang has more than 25 years of experience in chemical production management. He joined ScinoPharm in January, 1999 and has been in charge of the production unit for more than 15 years. Chih-Fang has been instrumental in enhancing productivity and production efficiency by introducing improvement initiatives and refining systems. Prior to joining ScinoPharm, Chih-Fang worked initially as process engineer, for Tasco Chemical Corporation in Kaohsiung and Tuntex Petrochemicals Inc. in Tainan from 1989 to 1998. Chih-Fang received both of his M.S. and B.S. in Chemical Engineering from National Cheng Kung University.
Kevin Yen | Vice President of Administration
Kevin Yen began his career with Uni-President Enterprise Corp. since 1986 and has held a number of managerial positions in the areas of finance, accounting, and treasury within the company and its affiliates. He was manager of Finance for two of the cooperation projects the Uni-President had with the Takashimaya department store between 2001 and 2003 and the Hankyu department store project between 2006 and 2011. He most recently served as a managerial position in accounting at Uni-President. Kevin graduated from Feng Chia University with a B.S. degree in accounting.
Gloria Chang | Vice President of Injectable Business Division Ph.D. Chemistry
Since joining the company in 1999, Dr. Chang has progressed through a series of increasingly responsible positions and had extensive experience in leading several important project initiatives. She had provided leadership to functional groups of quality control, analytical R&D, biotech, peptide product development, pharmaceutical development and the head of quality management division. Dr. Chang received her B.S. and Ph.D. degrees in Chemistry from National Taiwan University. Prior to joining ScinoPharm, she spent one and a half years as a postdoctoral fellow at Academia Sinica from 1997 to 1998.